|
PBDE Polybrominated diphenyl ether
What Fate for Brominated Fire Retardants?
Rebecca Renner / Environmental Science and Technology 1may00
A publication of the American Chemical Society
The widespread distribution and environmental effects of these
persistent chemicals are driving preventive measures.
The presence of polybrominated diphenyl ether (PBDE) flame retardants
throughout the world environment has begun to attract international
attention. Researchers and environmental groups are concerned
about emerging pollution problems, pointing both to the growing
body of evidence that PBDEs are ubiquitous in the environment
and to evidence suggesting that low-level exposures may produce
detrimental health effects in humans and animals.
European scientists and governments are at the forefront of this
issue, but the problem is global, according to Mehran Alaee, a
research scientist at Canada's National Water Research Institute,
in Burlington, Ontario, whose group is responsible for most of
the PBDE measurements in North America. "It's global because
so far, everywhere we look we find measurable amounts of PBDEs,"
Alaee says.
Although European governments are poised for action, PBDE manufacturers
claim that such measures are premature and simplistic. Producers
argue that bans and actions to remove these chemicals from the
marketplace are overly cautious and are based on inadequate data.
Legislative and regulatory control initiatives fail to account
for the benefits of flame retardants in preventing fires, and
little is known about the environmental fate and transport of
proposed substitutes, according to Marcia Hardy, who chairs the
Brominated Flame Retardants Industry Panel at the Chemical Manufacturers
Association in Washington, DC.
The study prompting the most activity so far is a finding by researchers
at Sweden's Karolinska Institute (1) that there are low levels
of PBDEs in mothers' milk and that, although levels of other persistent
organic pollutants, such as polychlorinated biphenyls (PCBs) and
DDT, are decreasing, levels of PBDEs are increasing. Results such
as these are the rationale for a draft European Union (EU) Human
Health Risk Assessment's recommendation that action be taken to
curb the use of penta-BDE (2), which is sold in relatively small
quantities.
"Penta is damned," says Gwynne Lyons, Toxics and Policy
Advisor to Worldwide Fund for Nature-UK, "The political decision-making
process, at least in Europe, will respond to the fact that no
mother on earth wants her breast milk to be contaminated with
flame-retardant chemicals." The EU includes restrictions
against PBDEs under the European ecolabeling scheme and is likely
to propose a much broader ban on their use in electrical and electronic
equipment under a forthcoming directive on scrap from electronic
devices.
The Swedish research results are also prompting action in the
United States, according to Larry Needham, Centers for Disease
Control and Prevention (CDC) director of toxicology. Needham notes
that CDC will begin gathering data on U.S. exposure this summer.
Unlike many persistent and ubiquitous organic pollutants such
as PCBs or DDT, which are largely a legacy of the past, brominated
flame retardants are in current, widespread use to prevent or
deter fires in electronic devices, furniture, and textiles. PBDEs
have been found in the body fat of many wildlife species, including
sperm whales in the Atlantic Ocean (3). The latter finding suggests
that even the deep ocean is now contaminated. Prompted by such
findings, Sweden and Denmark have called for a ban on two types
of flame retardantspolybrominated biphenyls (PBBs) and PBDEsand
are urging international action.
The largest-volume PBDE product on the market today is deca-BDE.
But because PBDE toxicity decreases as the number of bromines
increase, the deca-brominated compound is, at first glance, the
least likely to present a problem (4). Many researchers and environmental
groups believe, however, that in the environment, deca-BDE can
break down to lower congeners. "The toxicity of octa- and
deca-BDE, coupled with the concerns about their potential breakdown
to penta, is enough to warrant their removal from the market,"
argues Lyons.
Consumption and use Brominated diphenyl ethers are a group of
aromatic brominated compounds in which 1-10 hydrogen atoms in
the diphenyl oxide structure are replaced by bromine atoms. Commercially
available products are not pure substancesflame-retardant
formulations consist of PBDEs containing anywhere from 3 to 10
bromine atoms. Three different flame retardants are available
and are sold in the marketplace as penta-, octa-, and decabromodiphenyl
ether; each product is actually a mixture of brominated diphenyl
ethers.
PBBs, PBDEs, and tetrabromobisphenol A (TBBPA) are the main types
of brominated compounds used as flame retardants. PBDEs are the
focus of current concerns for several reasons. PBBsthe first
brominated organic compounds to be usedhave been voluntarily
phased out by manufacturers because of environmental issues. PBDEs
have taken their place but are now being replaced, to some extent,
by TBBPA. There is very little information available concerning
TBBPA (4).
The estimated annual global consumption of PBDEs in 1992 was 40,000
metric tons and consisted of 30,000 metric tons of decabromodiphenyl
ether, 6000 metric tons of octabromodiphenyl ether, and 4000 metric
tons of pentabromodiphenyl ether (2). Total PBDE consumption in
that year corresponded to about 30% of the world market for all
types of brominated fire retardants used. In western Europe, consumption
of PBDEs accounted for about 26% of the European market for brominated
flame retardants in 1996 (5). A 1999 analysis indicated that the
share of PBDEs in the European market decreased to about 11% in
1998 (5); the decrease in consumption of PBDEs is especially pronounced
in Germany, the Netherlands, and Nordic countries (5).
Members of the German Association of Chemical Industries voluntarily
halted production of PBDEs and PBBs (5) in 1986. In recent years,
leading European companies in the electric and electronic industries
have proclaimed an official policy of avoiding the use of PBDEs
and PBBs in their products.
PBDEs are currently used in plastic components of computers and
televisions, circuit boards, seats of cars and buses, and textiles
(4). It is important to distinguish between additive and reactive
uses. Reactive fire retardants such as TBBPA, are covalently bonded
to the plastic itself, while additives, such as PBDEs, are only
dissolved in the material. This means that reactive flame retardants
are less likely to leach out or volatilize, whereas additives
are more easily released.
Additive flame retardants are incorporated as components of plastic
mixtures either before, during, or, more frequently, following
polymerization. They are sometimes volatile and can tend to bleed,
so flame retardancy may be gradually lost. High molecular-weight,
plastic products, developed to enable plastics to be made more
permanently fire retardant, use the additive method for fire-retardant
protection. The most widely used brominated flame retardant additives
are PBDEs.
Ubiquity and a mystery PBDEs were first discovered in the environment
in 1981, when they were found in pike from western Sweden. Subsequent
reports, based on analyses of sediments, document the ubiquitous
distribution of PBDEs in the environment, wildlife andfish, human
adipose tissue, blood, and mother's milk (4). According to Alaee,
the presence of PBDEs in air samples from Alert, Northwest Territories
and from Duai, in Siberia confirm that, despite their relatively
low volatility, long-range atmospheric transport of these compounds
occurs.
Until recently, PBDE concentrations detected in wildlife and humans
have been below concentrations of PCBs and DDT. However, for certain
species, contamination levels are in the same range as for the
PCB congeners, according to a study by researchers from Sweden
and the United States, which was presented at the Dioxin '99 meeting
(6). The researchers compared PCB and PBDE levels in Steelhead
trout from Lake Michigan and Baltic salmon from the Baltic Sea
(see Figure 1, (7, 8)).
Despite the fact that human PBDE concentrations are significantly
lower than those of PCBs or DDT in mothers' milk, over the past
25 years, PBDE levels in breast milk have climbed to around 4
µg/kg of lipid content (1) (see Figure 2, (9)). The predominant
PBDEs in milk are tetra-BDEs, followed by penta-BDEs. A higher
PBDE concentration (28 µg/kg) was found by Swedish researchers
in one sample, but even this level of exposure is well below the
level so far shown to cause adverse effects on brain development
in animals.
Another Swedish study found levels up to 70 times higher than
normal in the blood serum of staff at an electronics dismantling
plant (10). The results show that PBDEs are bioavailable, according
to the study, and that "occupational exposure to PBDEs occurs
at the dismantling plant." The study also found deca-BDE
in individuals who were exposed at work. This is an important
observation, according to the authors, "because it has been
claimed that this compound is unlikely to bioaccumulate because
of its high relative molecular mass."
Although deca-BDE accounts for most PBDE consumption, it is the
lower congenerstetra-BDE and penta-BDE, and in particular
2,4,2´,4´-tetra-BDE and 2,4,5,2´,4´-penta-BDEthat
are most commonly found in the environment.
To explain this discrepancy, scientists theorize that higher congeners
break down in the environment. Such debromination has been demonstrated
in the laboratory, according to Åke Bergman, professor of
chemistry at Stockholm University, in Sweden, although there are
few published results to back this up. There are also indications
that debromination occurs in fish during metabolism, according
to Bo Jansson, at the Institute of Applied Environmental Research,
in Stockholm (11).
But Hardy, who is also an environmental chemist at PBDE manufacturer
Albemarle Corp., in Baton Rouge, LA, disagrees that debromination
happens in the environment. She theorizes that the congeners found
in the environment are the result of historic emissions that have
ceased. Penta-BDE was used for off-shore oil drilling on a trial
basis in the early 1990s. Until the late 1980s, it was also used
as a hydraulic fluid by the coal mining industry in Germany. Hardy
notes, for example, that sediment samples from the Mersey River
in England contain deca-BDE, tetra-BDE, and penta-BDE, but no
other congeners. "If deca-BDE is breaking down, then why
does it degrade down to a few specific congeners and then just
stop?" she asks. If deca-BDE were being degraded, all of
the intermediate congeners would be expected, she said.
In an attempt to address this question, a 36-week study to test
whether deca-BDE can debrominate in the environment is being performed
as part of the EU ecotoxicological risk assessment. Results are
expected to be available this year.
Sources and trends Although PBDE levels in mothers' milk appear
to be increasing, the trend of levels in the environment is unclear,
according to Steven Dungey, at UK's Environment Agency. "This
is a very tricky area," he says. "Although there are
now quite a lot of data available, few have been analyzed statistically
for trends." Since the early 1990s, Dungey has been reviewing
published and unpublished data as part of the EU ecotoxicity risk
assessment. Most of the monitoring data indicate that although
there may have been an increase in the levels of the most common
tetra- and penta-BDE congeners in biota over the 1980s, this has
now stabilized or is decreasing.
There are few data on PBDE emissions to the environment, according
to Dungey. Production and processing facilities may discharge
PBDEs; high levels are found downstream from some factories. Releases
can occur throughout the life cycleincluding recycling,
landfilling, or incinerationof products that contain PBDEs;
few quantitative data exist for these potential emissions sources.
In the EU ecotoxicity risk assessment, a series of "realistic
worst case" assumptions were made based on comparison with
the behavior of similar chemicals that are added to polymeric
materials. A study by the Danish EPA aimed at identifying the
flow of PBDEs into and out of Denmark encountered a similar lack
of information about sources. The study, based on product information
and scientific literature, concluded on the basis of model estimates
that the major source of PBDEs to the environment is evaporation
from products in use (5).
Another possible source for PBDEs in the environment could be
their natural synthesis, mainly by marine organisms, according
to Jan Boon at the Netherlands Institute for Sea Research, in
Texel. A vast range of naturally occurring organobromine compounds
are produced by marine and terrestrial plants, marine animals,
bacteria, fungi, and even humans (12). Marine sponges are known
to produce methoxylated PBDE (13). Although the specific PBDEs
of concern have not yet been found in nature, a natural source
is possible, according to Hardy, because only a small number of
the world's diverse organisms have been examined for their chemical
content.
Toxicity and unresolved issues There is little information available
about PBDE effects of toxicity on organisms in the environment
(4). One study is reported in which a young man developed symptoms
similar to that of dioxin exposure, which included chloracne on
the head and back, chronic pain in the face and skull, and lesions
on the sides of his feet (4). At the age of 13, he developed these
health problems after playing computer games for hours a day in
an unventilated room. When he was 21, PBDEs were found in his
fat and in different parts of the computer monitor. However, since
eight years elapsed between the possible exposure to PBDEs and
the sampling, there is no clear-cut answer to the question of
whether PBDEs played a role in affecting his health.
A study investigating possible neurobehavioral effects in neonatal
mice indicated that effects on brain development can occur at
low doses, if exposure occurs during a period of rapid brain development.
Per Eriksson and co-workers at Uppsala University in Sweden found
that even a single dose of tetra-BDE (0.7 mg/kg bw) or penta-BDE
(0.8 mg/kg bw) given to young mice affected their behavior in
later life (14). But the study suffers from limitations in statistical
analysis and reporting, so it is difficult to draw any firm conclusions,
according to the draft EU human health risk assessment of penta-BDE
(2).
Several studies indicate that commercially obtained penta- and
tetra-BDE are endocrine disrupters, which can exert effects on
the thyroid system (4). The effects of penta-BDE on thyroxine
and the thyroid gland are considered to be principally due to
the induction of liver enzymes, although several mechanisms may
operate. The liver appears to be sensitive, and for penta-BDE,
a no-observed-adverse-effect level of 1 mg/kg bw/day has been
determined, with effects evident at 2 mg/kg bw/day. The exposure
range for humans via food has been calculated as 0.2-0.7 mg per
day.
For the past two years, political interest in PBDEs has been high
in Europe. Taking the bold political initiative, Sweden and Denmark
called for bans in the midst of the EU risk assessment process.
In the United Kingdom, the Department of Trade and Industry in
1998 released a study (15) praising flame retardants for preventing
fires and saving lives and labeling opponents as "chemophobes".
The study, which only considered flame retardants in the home,
not in the environment, caused embarrassment to the United Kingdom's
Environment Agency, which is responsible for the environmental
risk assessment.
Unresolved scientific issues concerning PBDEs are currently the
topic of research efforts, which should soon yield preliminary
results. Findings of the debromination study should be out this
spring. A detailed study of PBDE levels in suspended particulate
matter, sediments, and biota from Dutch freshwater and coastal
locations is due to be presented at the Society of Environmental
Toxicologists and Chemists World Meeting in Brighton, United Kingdom,
in May. An interlaboratory study on the analysis of PBDEs is to
be presented at the Dioxin 2000 symposium in Monterey, CA, in
August.
In northern Europe, since 1996, there has been a trend (see box,
Ecolabs drive the search for substitutes) to substitute other
flame retardants for PBDEs. Whether the recommended ban on penta-BDE
will be extended to cover the other PBDE flame retardants remains
to be seen.
References
1. Darnerud, P.; Bergman, A.; Noren, K. Organohalogen Comp. 1998,
35, 387-390.
2. Diphenyl ether, pentabromo derivative, draft human health assessment
under EU existing substances regulation; 793/93/EEC; Health and
Safety Executive: Stanley Precinct, Bootle, Merseyside, U.K.,
1999.
3. deBoer, J., et al. Nature 1998, 394 (6688), 28-29.
4. deBoer, J.; deBoer, K.; Boon, J. P. Polybrominated Biphenyls
and Diphenyl Ethers. In The Handbook of Environmental Chemistry;
Paasivirta, J. Ed.; Springer Verlag: New York, 1999.
5. Danish Environmental Protection Agency Brominated Flame RetardantsSubstance
Flow Analysis and Assessment of Alternatives 1999. http://www.mst.dk
(accessed Dec. 1999).
6. Asplund, L., et al. Levels of polybrominated diphenyl ethers
(PBDEs) in fish from the Great Lakes and Baltic Sea. Presented
at Dioxin '99; Venice, 1999.
7. Asplund, L., et al. Organohalogen Comp. 2000, in press.
8. Asplund, L., et al. Ambio 1999, 28, 67.
9. Meironyté, D.; Norén, K.; Bergman, Å. J.
Toxicol. Environ. Health (Part A) 1999, 58 (6) 329-341.
10. Sjodin, A., et al. Environ. Health Persp. 1999, 107 (8), 643-648.
11. Kierkegaard, A., et al. Environ. Sci. Technol. 1999, 33 (11),
1612-1617.
12. Gribble, G. W. Acc. Chem. Res. 1998, 31 (3), 141-152.
13. Gribble, G.W. Chem. Soc. Rev. 1999, 28 (5), 335-346.
14. Eriksson, P.; Jakobsson, E.; Fredriksson A. Organohalogen
Comp. 1998, 35, 375-377.
15. Stevens, G. C.; Mann, A. H. Risks and benefits of the use
of flame retardants in consumer products; University of Surrey
Polymer Research Centre Report, U.K. Department of Trade and Industry:
Guildford, Surrey, U.K., 1999. Rebecca Renner is a contributing
editor of ES&T.
------------------------------------------------------------------------
Developmental Neurotoxicity of Polybrominated Diphenyl Ethers:
Mechanisms and Effects
Zürich University 5dec00
Polybrominated diphenyl ethers (PBDE) are increasingly used as
flame retardants (presently 180,000 tons/year). They bioaccumulate
in marine mammals, birds and humans. Levels in human milk recently
started to rise sharply, up to 4 ng/g lipid. The presence of lipophilic
compounds in maternal milk reflects the body burden of the maternal
organism and indicates the possibility of prenatal transplacental
exposure als well as postnatal exposure through milk. In contrast
to polychlorinated biphenyls (PCB), very little information is
available on the toxicity of PBDE. This is particularly true for
developmental neurotoxicity, but recent experimental evidence
by one of the project partners indicates a potential of adverse
effects on the developing nervous system. The present project
is designed to study developmental effects of PBDE on nervous
system in rodents and in in vitro models. In order to relate these
observations to known effects of PCB, a technical PCB mixture
(Aroclor 1254) is used as a positive control. Endpoints include
behavioral development, neurotransmitter systems and receptors,
intracellular signal transduction pathways, neuroendocrine mechanisms
and possible effects on glial function.
Since certain PCB congeners interfere with endocrine mechanisms,
this question will be addressed also for PBDE. Our laboratory
investigates effects of PBDE and of the PCB mixture on neuroendocrine
development in male and female Long Evans rat offspring, with
focus on sexual differentiation of brain and peripheral organs.
The program aims to link alterations in sexual functions of both
sexes (sexually dimorphic behaviors, gonadal functions) with developmental
changes in molecular endpoints, in particular regulation of sex
hormone-dependent gene expression in brain regions and genital
organs, and steroidogenic enzymes. Landmarks of postnatal sexual
ontogeny will also be monitored.
* Prof. Walter Lichtensteiger (Project Leader) lichtens@pharma.unizh.ch
* PD Dr. Margret Schlumpf (Project Leader) schlumpm@pharma.unizh.ch
* Supported By EU
Fifth Framework Program (EU), Quality of Life and Management of
Living Resources
* Research Program EU
* In Collaboration With University of Düsseldorf, Düsseldorf,
Germany / University of Rome, Rome, Italy / University of Uppsala,
Uppsala, Sweden / University of Valencia, Valencia, SpainResponsible
* Project Leader: Prof. Walter Lichtensteiger, PD Dr. Margret
* Professor or Research Area Leader: Prof. Dr. W. Lichtensteiger
* Institute or Clinic: Pharmakologie und Toxikologie, Institut
für
* Faculty: Medizinische Fakultät
* Comments to uniresearch
|